Scottish Brain Sciences (SBS) is revolutionizing Alzheimer's research! SBS, a powerhouse in clinical research, has unveiled a cutting-edge center at ONE BioHub, Aberdeen, dedicated to early detection and treatment. But here's where it gets personal...
This new facility is a beacon of hope for those living with Alzheimer's and memory concerns, offering them the chance to participate in groundbreaking studies. With this expansion, SBS adds a third research site to its portfolio, joining its St Andrews hub and Edinburgh HQ. The ONE BioHub location is a strategic move, positioning SBS alongside innovative startups and life science companies like NovaBiotics and Genomes.io.
The center's opening on November 14th was marked by the presence of research participant Lynne Carroll, who shared her journey to diagnosis. This powerful moment emphasized the importance of patient involvement in research. Richard Lochhead MSP, Minister for Business and Employment, also attended, highlighting SBS's contribution to Scotland's innovation and public health.
"The north-east deserves to be at the forefront of brain health and dementia research," said Professor Craig Ritchie, CEO and Founder of SBS. "This center ensures local participation in trials and advanced assessments, driving progress in Alzheimer's research." Ritchie's words resonate, emphasizing the power of patient involvement.
Lynne Carroll's perspective adds a layer of emotion: "A late diagnosis is a common struggle. Being part of research gives me hope for earlier detection and treatment. I'm thrilled to be part of this Aberdeen site, enabling me to contribute more actively." And this is the part most people miss—the profound impact of patient engagement.
Dr. Deborah O'Neil OBE FRSE, Chair of ONE Life Sciences and BioAberdeen Ltd., praised SBS's expansion, noting its contribution to the life sciences cluster. But is this expansion enough? Should more be done to involve patients in research and development?
The new SBS center at ONE BioHub promises to accelerate Alzheimer's research. Yet, it raises questions about patient engagement and its role in shaping medical advancements. What do you think? Is patient involvement in research a priority, or should it be more prominent? Share your thoughts in the comments!
